Literature DB >> 22516585

Molecular pathology.

Stanley R Hamilton1.   

Abstract

Molecular pathology as applied to neoplasia is a rapidly expanding component of the discipline of pathology that uses molecular biology tools in addition to conventional morphologic, immunohistochemical and chemical analyses of abnormalities in tissues and cells to understand the etiology and pathogenesis of tumors, establish their diagnosis, and contribute to prognostication and therapeutic decisions for cancer patient care. Biomarkers are a fundamental component of personalized cancer care, and the discipline of molecular pathology therefore contributes throughout the continuum from biomarker research to use in standard-of-care personalized cancer therapy. This brief review addresses some of the specific roles of molecular pathology in that continuum.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22516585      PMCID: PMC5528368          DOI: 10.1016/j.molonc.2012.02.007

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  17 in total

Review 1.  Diagnostics and biomarker development: priming the pipeline.

Authors:  Kathryn A Phillips; Stephanie Van Bebber; Amalia M Issa
Journal:  Nat Rev Drug Discov       Date:  2006-05-19       Impact factor: 84.694

Review 2.  Molecular diagnostics: harmonization through reference materials, documentary standards and proficiency testing.

Authors:  Marcia J Holden; Roberta M Madej; Philip Minor; Lisa V Kalman
Journal:  Expert Rev Mol Diagn       Date:  2011-09       Impact factor: 5.225

3.  Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers.

Authors:  Akash Kumar; Thomas A White; Alexandra P MacKenzie; Nigel Clegg; Choli Lee; Ruth F Dumpit; Ilsa Coleman; Sarah B Ng; Stephen J Salipante; Mark J Rieder; Deborah A Nickerson; Eva Corey; Paul H Lange; Colm Morrissey; Robert L Vessella; Peter S Nelson; Jay Shendure
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

Review 4.  Molecular testing of solid tumors.

Authors:  Anne Igbokwe; Dolores H Lopez-Terrada
Journal:  Arch Pathol Lab Med       Date:  2011-01       Impact factor: 5.534

Review 5.  Molecular pathology.

Authors:  Stanley R Hamilton
Journal:  Mol Oncol       Date:  2012-03-23       Impact factor: 6.603

6.  Decision analysis for the evaluation of diagnostic tests, prediction models and molecular markers.

Authors:  Andrew J Vickers
Journal:  Am Stat       Date:  2008       Impact factor: 8.710

Review 7.  The cancer genome.

Authors:  Michael R Stratton; Peter J Campbell; P Andrew Futreal
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

8.  Personalized oncology through integrative high-throughput sequencing: a pilot study.

Authors:  Sameek Roychowdhury; Matthew K Iyer; Dan R Robinson; Robert J Lonigro; Yi-Mi Wu; Xuhong Cao; Shanker Kalyana-Sundaram; Lee Sam; O Alejandro Balbin; Michael J Quist; Terrence Barrette; Jessica Everett; Javed Siddiqui; Lakshmi P Kunju; Nora Navone; John C Araujo; Patricia Troncoso; Christopher J Logothetis; Jeffrey W Innis; David C Smith; Christopher D Lao; Scott Y Kim; J Scott Roberts; Stephen B Gruber; Kenneth J Pienta; Moshe Talpaz; Arul M Chinnaiyan
Journal:  Sci Transl Med       Date:  2011-11-30       Impact factor: 17.956

9.  Integrated genomic analyses of ovarian carcinoma.

Authors: 
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

10.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

Authors: 
Journal:  Nature       Date:  2008-09-04       Impact factor: 49.962

View more
  7 in total

Review 1.  Molecular pathology.

Authors:  Stanley R Hamilton
Journal:  Mol Oncol       Date:  2012-03-23       Impact factor: 6.603

2.  A clinically relevant mouse model of canine osteosarcoma with spontaneous metastasis.

Authors:  Beth K Chaffee; Matthew J Allen
Journal:  In Vivo       Date:  2013 Sep-Oct       Impact factor: 2.155

Review 3.  The Cosmc connection to the Tn antigen in cancer.

Authors:  Tongzhong Ju; Rajindra P Aryal; Matthew R Kudelka; Yingchun Wang; Richard D Cummings
Journal:  Cancer Biomark       Date:  2014-01-01       Impact factor: 4.388

Review 4.  Cell-blocks and other ancillary studies (including molecular genetic tests and proteomics).

Authors:  Vinod B Shidham
Journal:  Cytojournal       Date:  2021-02-22       Impact factor: 2.091

5.  Individualized drug screening based on next generation sequencing and patient derived xenograft model for pancreatic cancer with bone metastasis.

Authors:  Zhonghai Guan; Huanrong Lan; Xiangheng Chen; Xiaoxia Jiang; Xuanwei Wang; Ketao Jin
Journal:  Mol Med Rep       Date:  2017-08-10       Impact factor: 2.952

6.  A potential novel therapy for FGFR1-amplified pancreatic cancer with bone metastasis, screened by next-generation sequencing and a patient-derived xenograft model.

Authors:  Zhonghai Guan; Huanrong Lan; Dan Sun; Xuanwei Wang; Ketao Jin
Journal:  Oncol Lett       Date:  2018-12-28       Impact factor: 2.967

7.  Unique volatolomic signatures of TP53 and KRAS in lung cells.

Authors:  M P A Davies; O Barash; R Jeries; N Peled; M Ilouze; R Hyde; M W Marcus; J K Field; H Haick
Journal:  Br J Cancer       Date:  2014-07-22       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.